Effects of E4/DRSP on self-reported physical and emotional premenstrual and menstrual symptoms: data from the phase 3 clinical trial in Europe and Russia.
Johannes BitzerCéline BouchardJános ZatikSteven WeyersTerhi PiltonenLarisa SuturinaInna ApolikhinaKristina Gemzell-DanielssonMaud JostMitchell D CreininJean-Michel FoidartPublished in: The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception (2024)
E4/DRSP starters experienced significant improvements in the domains Pain, Water Retention and Negative Affect particularly benefiting those with more severe baseline symptoms. Switchers showed minimal changes.